参考文献/References:
[1] James CV,Moonesinghe R,Wilson-Frederick SM,et al. Racial/ethnic health disparities among rural adults-United States, 2012-2015[J]. MMWR Surveill Summ,2017,66(23):1-9. DOI:10.15585/mmwr.ss6623a1.
[2] 中国肥胖问题工作组数据汇总分析协作组.我国成人体重指数和腰围对相关疾病危险因素异常的预测价值:适宜体重指数和腰围切点的研究[J]. 中华流行病学杂志,2002,23(1):5-10.DOI:10.3760/j.issn:0254-6450.2002.01.003.
[3] Wang GJ,Geliebter A,Volkow ND,et al. Enhanced striatal dopamine release during food stimulation in binge eating disorder[J].Obesity(Silver Spring),2011,19(8):1601-1608.DOI:10.1038/oby.2011.27.
[4] Johnson PM,Kenny PJ.Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats[J].Nat Neurosci,2010,13(5):635-641.DOI:10.1038/nn.2519.
[5] Wang GJ,Volkow ND,Logan J,et al.Brain dopamine and obesity[J].Lancet,2001,357(9253):354-357.
[6] Hogenkamp PS,Zhou W,Dahlberg LS,et al.Higher resting-state activity in reward-related brain circuits in obese versus normal-weight females independent of food intake[J].Int J Obes(Lond),2016,40(11):1687-1692.DOI:10.1038/ijo.2016.105.
[7] Kenny PJ.Reward mechanisms in obesity: new insights and future directions[J].Neuron,2011,69(4):664-679.DOI:10.1016/j.neuron.2011.02.016.
[8] Brown HD,McCutcheon JE,Cone JJ,et al.Primary food reward and reward-predictive stimuli evoke different patterns of phasic dopamine signaling throughout the striatum[J].Eur J Neurosci,2011,34(12):1997-2006.DOI:10.1111/j.1460-9568.2011.07914.x.
[9] Singh M. Mood, food and obesity[J]. Front Psychol,2014,5:925.DOI:10.3389/fpsyg.2014.00925.
[10] Taylor VH,Curtis CM,Davis C.The obesity epidemic: the role of addiction[J].CMAJ,2010,182(4):327-328.DOI:10.1503/cmaj.091142.
[11] Cone JJ,McCutcheon JE,Roitman MF.Ghrelin acts as an interface between physiological state and phasic dopamine signaling[J].J Neurosci,2014,34(14):4905-4913.DOI:10.1523/JNEUROSCI.4404-13.2014.
[12] Volkow ND,Wang GJ,Fowler JS,et al.Food and drug reward: overlapping circuits in human obesity and addiction[J].Curr Top Behav Neurosci,2012,11:1-24.DOI:10.1007/7854_2011_169.
[13] Volkow ND,Wang GJ,Baler RD.Reward, dopamine and the control of food intake: implications for obesity[J].Trends Cogn Sci,2011,15(1):37-46.DOI:10.1016/j.tics.2010.11.001.
[14] Carlin J,Hill-Smith TE,Lucki I,et al.Reversal of dopamine system dysfunction in response to high-fat diet[J].Obesity(Silver Spring),2013,21(12):2513-2521.DOI:10.1002/oby.20374.
[15] Johnson PM,Kenny PJ.Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats[J].Nat Neurosci,2010,13(5):635-641.DOI:10.1038/nn.2519.
[16] Blum K,Thanos PK,Gold MS.Dopamine and glucose, obesity, and reward deficiency syndrome[J].Front Psychol,2014,5:919.DOI:10.3389/fpsyg.2014.00919.
[17] Blum K, Sheridan PJ, Wood RC,et al. The D2 dopamine receptor gene as a determinant of reward deficiency syndrome[J].J R Soc Med,1996,89(7):396-400.
[18] Bina KG,Cincotta AH.Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice[J].Neuroendocrinology,2000,71(1):68-78.DOI:10.1159/000054522.
[19] Knab AM,Bowen RS,Hamilton AT,et al.Pharmacological manipulation of the dopaminergic system affects wheel-running activity in differentially active mice[J].J Biol Regul Homeost Agents,2012,26(1):119-129.
[20] Salamone JD,Correa M.The mysterious motivational functions of mesolimbic dopamine[J].Neuron,2012,76(3):470-485.DOI:10.1016/j.neuron.2012.10.021.
[21] Knab AM,Bowen RS,Hamilton AT,et al.Altered dopaminergic profiles: implications for the regulation of voluntary physical activity[J].Behav Brain Res,2009,204(1):147-152.DOI:10.1016/j.bbr.2009.05.034.
[22] Apovian CM,Aronne LJ,Bessesen DH,et al.Pharmacological management of obesity: an endocrine Society clinical practice guideline[J].J Clin Endocrinol Metab,2015,100(2):342-362.DOI:10.1210/jc.2014-3415.
[23] Heal DJ,Gosden J,Smith SL.What is the prognosis for new centrally-acting anti-obesity drugs?[J].Neuropharmacology,2012,63(1):132-146.DOI:10.1016/j.neuropharm.2012.01.017.
[24] Carroll FI, Blough BE, Mascarella SW, et al. Chapter five-bupropion and bupropion analogsas treatments for CNSD isorders//Linda P. Dwoskin, eds. Advancesin pharmacology[M].69nd ed.New:Academic Press.2014:177-216.
[25] Gadde KM,Allison DB,Ryan DH,et al.Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults(CONQUER): a randomised, placebo-controlled, phase 3 trial[J].Lancet,2011,377(9774):1341-1352.DOI:10.1016/S0140-6736(11)60205-5.
[26] Li J,Xu J,Hou R,et al.Qing-Hua Granule induces GLP-1 secretion via bitter taste receptor in db/db mice[J].Biomed Pharmacother,2017,89:10-17.DOI:10.1016/j.biopha.2017.01.168.
[27] Xu Y,Lu Y,Xu P,et al.VMAT2-mediated neurotransmission from midbrain leptin receptor neurons in feeding regulation[J].eNeuro,2017,4(3). pii: ENEURO.0083-17.2017.DOI:10.1523/ENEURO.0083-17.2017.
[28] Fortin SM,Roitman MF.Central GLP-1 receptor activation modulates cocaine-evoked phasic dopamine signaling in the nucleus accumbens core[J].Physiol Behav,2017,176:17-25.DOI:10.1016/j.physbeh.2017.03.019.
[29] Richard JE,Anderberg RH,Göteson A,et al.Activation of the GLP-1 receptors in the nucleus of the solitary tract reduces food reward behavior and targets the mesolimbic system[J].PLoS One,2015,10(3):e0119034.DOI:10.1371/journal.pone.0119034.
[30] Clemmensen C,Müller TD,Woods SC,et al.Gut-brain cross-talk in metabolic control[J].Cell,2017,168(5):758-774.DOI:10.1016/j.cell.2017.01.025.
相似文献/References:
[1]曹琳,杨昱,刘超.减重手术对多囊卵巢综合征的治疗作用[J].国际内分泌代谢杂志,2014,(06):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
Cao Lin,Yang Yu,Liu Chao..Therapeutic effects of bariatric surgery on polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2014,(02):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
[2]张莎莎,孟杰杰,沈桂芬,等.肌肉生长抑制素前肽基因干预对高脂饮食诱导的肥胖小鼠脂代谢的影响[J].国际内分泌代谢杂志,2014,(06):361.[doi:10.3760/cma.j.issn.1673-4157.2014.06.001]
Zhang Shasha*,Meng Jiejie,Shen Guifen,et al.Effects of myostatin propeptide gene intervention on dyslipidemia in high fat diet-induced obese mice[J].International Journal of Endocrinology and Metabolism,2014,(02):361.[doi:10.3760/cma.j.issn.1673-4157.2014.06.001]
[3]郝圆圆,张婷婷,袁红网,等.增食欲素干预单纯性肥胖的作用及机制[J].国际内分泌代谢杂志,2014,(05):324.[doi:10.3760/cma.j.issn.1673-4157.2014.05.010]
Hao Yuanyuan,Zhang Tingting,Yuan Hongwang,et al.Effects of orexin on obesity and its mechanism[J].International Journal of Endocrinology and Metabolism,2014,(02):324.[doi:10.3760/cma.j.issn.1673-4157.2014.05.010]
[4]史俊奇 邹朝春.MicroRNA与肥胖[J].国际内分泌代谢杂志,2015,(05):344.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.014]
Shi Junqi,Zou Chaochun..MicroRNA and obesity[J].International Journal of Endocrinology and Metabolism,2015,(02):344.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.014]
[5]张如意 张桦 王娇 孙嘉 陈容平 杨锐 冉建民 陈宏.超重或肥胖2型糖尿病患者糖尿病足的
患病率及相关危险因素分析[J].国际内分泌代谢杂志,2015,(06):365.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.002]
Zhang Ruyi*,Zhang Hua,Wang Jiao,et al.Prevalence and risk factors for diabetic foot in overweight or obese type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(02):365.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.002]
[6]刘剑 吴明昊 高宇.高脂饮食影响消化系统致肥胖的机制[J].国际内分泌代谢杂志,2015,(06):402.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.011]
Liu Jian*,Wu Minghao,Gao Yu..The mechanism of obesity caused by disturbance of high fat diets on gastrointestinal system[J].International Journal of Endocrinology and Metabolism,2015,(02):402.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.011]
[7]张琳,费雯婕,宋光耀.网膜素与代谢综合征[J].国际内分泌代谢杂志,2016,36(01):42.[doi:10.3760/cma.j.issn.1673-4157.2016.01.010]
Zhang Lin*,Fei Wenjie,Song Guangyao..Omentin and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2016,36(02):42.[doi:10.3760/cma.j.issn.1673-4157.2016.01.010]
[8]谢绍锋,黄莉吉,王昆,等.南京市城区40岁以上人群超重、肥胖流行
特点调查分析[J].国际内分泌代谢杂志,2016,36(03):145.[doi:10.3760/cma.j.issn.1673-4157.2016.03.01]
Xie Shaofeng*,Huang Liji,Wang Kun,et al.Epidemiological investigation of overweight and obesity in population aged 40 years or older in Nanjing City[J].International Journal of Endocrinology and Metabolism,2016,36(02):145.[doi:10.3760/cma.j.issn.1673-4157.2016.03.01]
[9]杨曦,刘玉洁,马慧娟.C1q/肿瘤坏死因子相关蛋白12与糖代谢[J].国际内分泌代谢杂志,2016,36(03):195.[doi:10.3760/cma.j.issn.1673-4157.2016.03.13]
Yang Xi*,Liu Yujie,Ma Huijuan..C1q/tumor necrosis factor-related protein 12 and glucose metabolism[J].International Journal of Endocrinology and Metabolism,2016,36(02):195.[doi:10.3760/cma.j.issn.1673-4157.2016.03.13]
[10]赵一璟,陈国芳,刘超.代餐饮食在肥胖和超重患者中的应用[J].国际内分泌代谢杂志,2016,36(05):323.[doi:10.3760/cma.j.issn.1673-4157.2016.05.10]
Zhao Yijing*,Chen Guofang,Liu Chao.Application of meal replacement in obese and overweight patients[J].International Journal of Endocrinology and Metabolism,2016,36(02):323.[doi:10.3760/cma.j.issn.1673-4157.2016.05.10]